Toltec Pharmaceuticals, LLC: Clinical Trials

1 trial sponsored by Toltec Pharmaceuticals, LLC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Toltec Pharmaceuticals, LLC: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TOL-463 Phase 2 Study for Vaginitis
TOL-463 - Bacterial Vaginosis, Vulvovaginal Candidiasis
Phase 2CompletedToltec Pharmaceuticals, LLC1062016-07-152018-03-09

Conditions studied

Candidiasis (1)  ·  Candidiasis, Vulvovaginal (1)  ·  Vaginitis (1)  ·  Vaginosis, Bacterial (1)

Interventions

TOL-463 (1)

Countries

United States (1)

Results publications

PMID 30184181